Novel targeted therapeutics: inhibitors of MDM2, ALK and PARPYuan Yuan(City of Hope), Hamid Mirshahidi(Loma Linda University)Journal of Hematology & OncologyApril 20, 201110.1186/1756-8722-4-16Cited by 120SaveCiteExport RISWatch citationsRelated PapersCombination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancer|Scientific Reports|2019|33